Literature DB >> 25732877

[Investigation of Pneumocystis jirovecii colonization in patients with pulmonary diseases].

Soykan Özkoç1, Songül Bayram Delibaş, Ahmet Emin Erbaycu, Ceren Ergüden, Çiler Akısü.   

Abstract

OBJECTIVE: The detection of Pneumocystis jirovecii or its DNA in respiratory samples from individuals who do not have signs or symptoms of pneumonia has been defined as colonization. In this study, we aimed to investigate the prevalence of P. jirovecii colonization in patients with various lung diseases.
METHODS: Thirty patients who were followed-up and who had undergone bronchoscopy for diagnosis of different underlying diseases or pulmonary signs were included in the study. Bronchoalveolar lavage (BAL) fluids of these patients were analyzed with nPCR amplification of the mt-LSUrRNA gene of P. jirovecii. In addition to nPCR, giemsa, Gomori's methenamine silver (GMS), and indirect fluorescence antibody (IFA) staining assays were applied to all samples.
RESULTS: P. jirovecii DNA was detected in 21 of 30 (70%) BAL samples by nPCR. However, P. jirovecii cysts were found in 1 of 21 nPCR-positive samples by giemsa and GMS. IFA assay showed six samples to be positive, but only four of them were found to be positive by nPCR.
CONCLUSION: Result of our study showed that prevalence of P. jirovecii colonization is particularly high in patients with chronic pulmonary diseases, and nPCR was a good assay for evaluation of the colonization of P. jirovecii.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25732877     DOI: 10.5152/tpd.2014.3611

Source DB:  PubMed          Journal:  Turkiye Parazitol Derg        ISSN: 1300-6320


  2 in total

1.  Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China.

Authors:  Dong-Dong Wang; Ming-Quan Zheng; Nan Zhang; Chun-Li An
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-29

2.  Pneumocystis jirovecii colonization and its association with pulmonary diseases: a multicenter study based on a modified loop-mediated isothermal amplification assay.

Authors:  Ting Xue; Zhuang Ma; Fan Liu; Weiqin Du; Li He; Jinyan Wang; Chunli An
Journal:  BMC Pulm Med       Date:  2020-03-20       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.